Varlamov, Elena V.
Akirov, Amit
Gheorghiu, Monica L.
Fleseriu, Maria https://orcid.org/0000-0001-9284-6289
Article History
Received: 8 December 2025
Accepted: 8 January 2026
First Online: 6 February 2026
Declarations
:
: The authors declare no competing interests.
: EVV has received research grants to University from Recordati and Novo Nordisk. AA has received occasional scientific fee for scientific consulting and advisory boards from Medison, CTS pharma, and Neopharm, MF has received scientific consulting fees from Alexion, DebioPharm, Camurus, Crinetics, Recordati, Sparrow and Xeris and research support to University from Alexion, DebioPharm, Crinetics and Sparrow. MLG has no conflicts of interests.